Patch Testing with a New Composition of Mercapto Mix: A Multi-centre Study by the Swedish Contact Dermatitis Research Group

Acta Derm Venereol. 2019 Oct 1;99(11):960-963. doi: 10.2340/00015555-3249.

Abstract

This study investigated whether more patients with contact allergies were detected by patch testing with mercapto mix with a higher concentration of 2-mercaptobenzothiazolinone (MBT) than the commonly used mercapto mix. A total of 3,143 dermatitis patients in 5 Swedish dermatology departments were patch- tested with 3 mercapto test preparations: MBT 2.0% petrolatum (pet.); mercapto mix 2.0% pet.; and mercapto mix 3.5% pet. Positive reactions to these mercapto mixes varied between 0-0.50%, 0-0.93%, and 0-1.4%, respectively, in the 5 centres. Numerically, mercapto mix 3.5% pet. detected all positive patients and more patch-test positive patients than did the 2 other substances, but the difference was not statistically significant. The authors recommend replacing mercapto mix 2.0% pet. in the Swedish baseline series with mercapto mix 3.5% pet., since the latter also detected those patients who would have been missed because MBT 2.0% is not included in the Swedish baseline series.

Keywords: 2-mercaptobenzothiazole; contact allergy; delayed hypersensitivity; mercapto mix; rubber; allergic contact dermatitis.

Publication types

  • Multicenter Study

MeSH terms

  • Administration, Cutaneous
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Benzothiazoles / administration & dosage*
  • Child
  • Dermatitis, Allergic Contact / diagnosis*
  • Dermatitis, Allergic Contact / immunology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patch Tests*
  • Predictive Value of Tests
  • Reproducibility of Results
  • Sweden
  • Young Adult

Substances

  • Benzothiazoles
  • dibenzothiazyl disulfide